Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
9
×
biotech
national blog main
boston blog main
san francisco blog main
boston top stories
clinical trials
medical device
national top stories
new york blog main
san francisco top stories
cancer
ipo
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
investing
novartis
seattle blog main
seattle top stories
startups
wisconsin blog main
wisconsin top stories
biotech ipos
boston
democrats
exome
What
public
9
×
ipo
company
life
biotech
firms
science
week
companies
developing
drugs
files
haul
healthcare
initial
markets
million
new
offering
private
raised
san
sciences
tests
therapeutics
way
acelity
advance
america
answer
antonio
away
bio
biogen
biology
biotechs
blood
boost
broader
cancer
Language
unset
Current search:
public
×
" life sciences "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M